Table 2

Procedure Characteristics

Zotarolimus-Eluting Stent (n = 1,502)Biolimus-Eluting Stent (n = 1,497)p Value
More than 1 stent
 Per patient534 (35.9)481 (32.6)0.057
 Per lesion334 (17.8)278 (15.6)0.016
Total stent length (mm)
 Per patient21.0 (15.0–30.0)18.0 (14.0–29.0)0.0007
 Per lesion18.0 (14.0–24.0)18.0 (14.0–24.0)0.0021
Direct stenting277 (14.9)272 (15.4)0.67
Stent delivery failure
 Per patient26 (1.7)34 (2.3)0.29
 Per lesion27 (1.4)30 (1.7)0.59
Maximum pressure (atm)16.0 (12.0–18.0)16.0 (12.0–18.0)0.19
Length of procedure (min)22.0 (15.0–36.0)21.0 (15.0–33.0)0.057
Contrast (ml)85.0 (60.0–120.0)80.0 (60.0–120.0)0.17
Use of aspirin1,478 (98.4)1,458 (97.5)0.07
Use of clopidogrel1,099 (73.2)1,096 (73.6)0.94
Use of ticagrelor313 (20.8)300 (20.0)0.49
Use of prasugrel6 (0.4)10 (0.7)0.31
Use of glycoprotein IIb/IIIa inhibitors72 (4.8)78 (5.2)0.60

Values are n (%) or median (interquartile range).